Reference listed drugs (RLD) for submission to EMEA [Regulatives / Guidelines]

posted by ElMaestro  – Denmark, 2013-07-31 15:26 (4717 d 23:27 ago) – Posting: # 11135
Views: 7,248

Hi Sparsh,

❝ How to find reference listed drugs (RLD) for submission to EMEA.



This is the slightly wrong question to ask. They have RLD's in the US and the system works in different ways in Europe.
For EU submission (let's call it that in stead of EMEA/EMA submission. The latter would only be CP, and this is rarely what anyone wants for an abbridged dossier) you can copy pretty much any originator drug. As long as you are not conducting BE studies against a 10.1/10.2 or 10.3 approved product you will be in the clear as a general rule, at least when you are not in breach of exclusivity and all that stuff.

Try and read article 10.1 of directive 2001/83. which defines a reference product. You could also surf around on the HMA/CMD(h) websites for things like European reference product, global marketing authorisation etc.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
165 visitors (0 registered, 165 guests [including 14 identified bots]).
Forum time: 14:54 CEST (Europe/Vienna)

Try to learn something about everything
and everything about something.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5